Copyright Reports & Markets. All rights reserved.

Global (United States, European Union and China) Urolithiasis Management Device Market Research Report 2019-2025

Request for Sample of this report
Buy now

Table of Contents

    1 Report Overview

    • 1.1 Research Scope
    • 1.2 Major Manufacturers Covered in This Report
    • 1.3 Market Segment by Type
      • 1.3.1 Global Urolithiasis Management Device Market Size Growth Rate by Type (2019-2025)
      • 1.3.2 Extracorporeal Shock Wave Lithotripsy (Eswl)
      • 1.3.3 Intracorporeal Lithotripsy
      • 1.3.4 Percutaneous Nephrolithotomy
      • 1.3.5 Other Treatments
    • 1.4 Market Segment by Application
      • 1.4.1 Global Urolithiasis Management Device Market Share by Application (2019-2025)
      • 1.4.2 Hospitals
      • 1.4.3 Clinics
      • 1.4.4 Other
    • 1.5 Study Objectives
    • 1.6 Years Considered

    2 Global Growth Trends

    • 2.1 Production and Capacity Analysis
      • 2.1.1 Global Urolithiasis Management Device Production Value 2014-2025
      • 2.1.2 Global Urolithiasis Management Device Production 2014-2025
      • 2.1.3 Global Urolithiasis Management Device Capacity 2014-2025
      • 2.1.4 Global Urolithiasis Management Device Marketing Pricing and Trends
    • 2.2 Key Producers Growth Rate (CAGR) 2019-2025
      • 2.2.1 Global Urolithiasis Management Device Market Size CAGR of Key Regions
      • 2.2.2 Global Urolithiasis Management Device Market Share of Key Regions
    • 2.3 Industry Trends
      • 2.3.1 Market Top Trends
      • 2.3.2 Market Drivers

    3 Market Share by Manufacturers

    • 3.1 Capacity and Production by Manufacturers
      • 3.1.1 Global Urolithiasis Management Device Capacity by Manufacturers
      • 3.1.2 Global Urolithiasis Management Device Production by Manufacturers
    • 3.2 Revenue by Manufacturers
      • 3.2.1 Urolithiasis Management Device Revenue by Manufacturers (2014-2019)
      • 3.2.2 Urolithiasis Management Device Revenue Share by Manufacturers (2014-2019)
      • 3.2.3 Global Urolithiasis Management Device Market Concentration Ratio (CR5 and HHI)
    • 3.3 Urolithiasis Management Device Price by Manufacturers
    • 3.4 Key Manufacturers Urolithiasis Management Device Plants/Factories Distribution and Area Served
    • 3.5 Date of Key Manufacturers Enter into Urolithiasis Management Device Market
    • 3.6 Key Manufacturers Urolithiasis Management Device Product Offered
    • 3.7 Mergers & Acquisitions, Expansion Plans

    4 Market Size by Type

    • 4.1 Production and Production Value for Each Type
      • 4.1.1 Extracorporeal Shock Wave Lithotripsy (Eswl) Production and Production Value (2014-2019)
      • 4.1.2 Intracorporeal Lithotripsy Production and Production Value (2014-2019)
      • 4.1.3 Percutaneous Nephrolithotomy Production and Production Value (2014-2019)
      • 4.1.4 Other Treatments Production and Production Value (2014-2019)
    • 4.2 Global Urolithiasis Management Device Production Market Share by Type
    • 4.3 Global Urolithiasis Management Device Production Value Market Share by Type
    • 4.4 Urolithiasis Management Device Ex-factory Price by Type

    5 Market Size by Application

    • 5.1 Overview
    • 5.2 Global Urolithiasis Management Device Consumption by Application

    6 Production by Regions

    • 6.1 Global Urolithiasis Management Device Production (History Data) by Regions 2014-2019
    • 6.2 Global Urolithiasis Management Device Production Value (History Data) by Regions
    • 6.3 United States
      • 6.3.1 United States Urolithiasis Management Device Production Growth Rate 2014-2019
      • 6.3.2 United States Urolithiasis Management Device Production Value Growth Rate 2014-2019
      • 6.3.3 Key Players in United States
      • 6.3.4 United States Urolithiasis Management Device Import & Export
    • 6.4 European Union
      • 6.4.1 European Union Urolithiasis Management Device Production Growth Rate 2014-2019
      • 6.4.2 European Union Urolithiasis Management Device Production Value Growth Rate 2014-2019
      • 6.4.3 Key Players in European Union
      • 6.4.4 European Union Urolithiasis Management Device Import & Export
    • 6.5 China
      • 6.5.1 China Urolithiasis Management Device Production Growth Rate 2014-2019
      • 6.5.2 China Urolithiasis Management Device Production Value Growth Rate 2014-2019
      • 6.5.3 Key Players in China
      • 6.5.4 China Urolithiasis Management Device Import & Export
    • 6.6 Rest of World
      • 6.6.1 Japan
      • 6.6.2 Korea
      • 6.6.3 India
      • 6.6.4 Southeast Asia

    7 Urolithiasis Management Device Consumption by Regions

    • 7.1 Global Urolithiasis Management Device Consumption (History Data) by Regions
    • 7.2 United States
      • 7.2.1 United States Urolithiasis Management Device Consumption by Type
      • 7.2.2 United States Urolithiasis Management Device Consumption by Application
    • 7.3 European Union
      • 7.3.1 European Union Urolithiasis Management Device Consumption by Type
      • 7.3.2 European Union Urolithiasis Management Device Consumption by Application
    • 7.4 China
      • 7.4.1 China Urolithiasis Management Device Consumption by Type
      • 7.4.2 China Urolithiasis Management Device Consumption by Application
    • 7.5 Rest of World
      • 7.5.1 Rest of World Urolithiasis Management Device Consumption by Type
      • 7.5.2 Rest of World Urolithiasis Management Device Consumption by Application
      • 7.5.1 Japan
      • 7.5.2 Korea
      • 7.5.3 India
      • 7.5.4 Southeast Asia

    8 Company Profiles

    • 8.1 Allengers Medical Systems Ltd.
      • 8.1.1 Allengers Medical Systems Ltd. Company Details
      • 8.1.2 Company Description and Business Overview
      • 8.1.3 Production and Revenue of Urolithiasis Management Device
      • 8.1.4 Urolithiasis Management Device Product Introduction
      • 8.1.5 Allengers Medical Systems Ltd. Recent Development
    • 8.2 Boston Scientific Corporation
      • 8.2.1 Boston Scientific Corporation Company Details
      • 8.2.2 Company Description and Business Overview
      • 8.2.3 Production and Revenue of Urolithiasis Management Device
      • 8.2.4 Urolithiasis Management Device Product Introduction
      • 8.2.5 Boston Scientific Corporation Recent Development
    • 8.3 C.R. Bard, Inc.
      • 8.3.1 C.R. Bard, Inc. Company Details
      • 8.3.2 Company Description and Business Overview
      • 8.3.3 Production and Revenue of Urolithiasis Management Device
      • 8.3.4 Urolithiasis Management Device Product Introduction
      • 8.3.5 C.R. Bard, Inc. Recent Development
    • 8.4 Cook Medical
      • 8.4.1 Cook Medical Company Details
      • 8.4.2 Company Description and Business Overview
      • 8.4.3 Production and Revenue of Urolithiasis Management Device
      • 8.4.4 Urolithiasis Management Device Product Introduction
      • 8.4.5 Cook Medical Recent Development
    • 8.5 ConMed Corporation
      • 8.5.1 ConMed Corporation Company Details
      • 8.5.2 Company Description and Business Overview
      • 8.5.3 Production and Revenue of Urolithiasis Management Device
      • 8.5.4 Urolithiasis Management Device Product Introduction
      • 8.5.5 ConMed Corporation Recent Development
    • 8.6 DirexGroup
      • 8.6.1 DirexGroup Company Details
      • 8.6.2 Company Description and Business Overview
      • 8.6.3 Production and Revenue of Urolithiasis Management Device
      • 8.6.4 Urolithiasis Management Device Product Introduction
      • 8.6.5 DirexGroup Recent Development
    • 8.7 Dornier MedTech GmbH
      • 8.7.1 Dornier MedTech GmbH Company Details
      • 8.7.2 Company Description and Business Overview
      • 8.7.3 Production and Revenue of Urolithiasis Management Device
      • 8.7.4 Urolithiasis Management Device Product Introduction
      • 8.7.5 Dornier MedTech GmbH Recent Development
    • 8.8 Guangzhou Potent Optotronic Technology Co., Ltd.
      • 8.8.1 Guangzhou Potent Optotronic Technology Co., Ltd. Company Details
      • 8.8.2 Company Description and Business Overview
      • 8.8.3 Production and Revenue of Urolithiasis Management Device
      • 8.8.4 Urolithiasis Management Device Product Introduction
      • 8.8.5 Guangzhou Potent Optotronic Technology Co., Ltd. Recent Development
    • 8.9 HealthTronics, Inc.
      • 8.9.1 HealthTronics, Inc. Company Details
      • 8.9.2 Company Description and Business Overview
      • 8.9.3 Production and Revenue of Urolithiasis Management Device
      • 8.9.4 Urolithiasis Management Device Product Introduction
      • 8.9.5 HealthTronics, Inc. Recent Development
    • 8.10 Karl Storz GmbH & Co. KG
      • 8.10.1 Karl Storz GmbH & Co. KG Company Details
      • 8.10.2 Company Description and Business Overview
      • 8.10.3 Production and Revenue of Urolithiasis Management Device
      • 8.10.4 Urolithiasis Management Device Product Introduction
      • 8.10.5 Karl Storz GmbH & Co. KG Recent Development
    • 8.11 Lumenis
    • 8.12 Olympus Corporation
    • 8.13 Richard Wolf
    • 8.14 Siemens Healthcare

    9 Market Forecast

    • 9.1 Global Market Size Forecast
      • 9.1.1 Global Urolithiasis Management Device Capacity, Production Forecast 2019-2025
      • 9.1.2 Global Urolithiasis Management Device Production Value Forecast 2019-2025
    • 9.2 Market Forecast by Regions
      • 9.2.1 Global Urolithiasis Management Device Production and Value Forecast by Regions 2019-2025
      • 9.2.2 Global Urolithiasis Management Device Consumption Forecast by Regions 2019-2025
    • 9.3 United States
      • 9.3.1 Production and Value Forecast in United States
      • 9.3.2 Consumption Forecast in United States
    • 9.4 European Union
      • 9.4.1 Production and Value Forecast in European Union
      • 9.4.2 Consumption Forecast in European Union
    • 9.5 China
      • 9.5.1 Production and Value Forecast in China
      • 9.5.2 Consumption Forecast in China
    • 9.6 Rest of World
      • 9.6.1 Japan
      • 9.6.2 Korea
      • 9.6.3 India
      • 9.6.4 Southeast Asia
    • 9.7 Forecast by Type
      • 9.7.1 Global Urolithiasis Management Device Production Forecast by Type
      • 9.7.2 Global Urolithiasis Management Device Production Value Forecast by Type
    • 9.8 Consumption Forecast by Application

    10 Value Chain and Sales Channels Analysis

    • 10.1 Value Chain Analysis
    • 10.2 Sales Channels Analysis
      • 10.2.1 Urolithiasis Management Device Sales Channels
      • 10.2.2 Urolithiasis Management Device Distributors
    • 10.3 Urolithiasis Management Device Customers

    11 Opportunities & Challenges, Threat and Affecting Factors

    • 11.1 Market Opportunities
    • 11.2 Market Challenges
    • 11.3 Porter's Five Forces Analysis

    12 Key Findings

      13 Appendix

      • 13.1 Research Methodology
        • 13.1.1 Methodology/Research Approach
          • 13.1.1.1 Research Programs/Design
          • 13.1.1.2 Market Size Estimation
          • 13.1.1.3 Market Breakdown and Data Triangulation
        • 13.1.2 Data Source
          • 13.1.2.1 Secondary Sources
          • 13.1.2.2 Primary Sources
      • 13.2 Author Details

      In 2019, the market size of Urolithiasis Management Device is million US$ and it will reach million US$ in 2025, growing at a CAGR of from 2019; while in China, the market size is valued at xx million US$ and will increase to xx million US$ in 2025, with a CAGR of xx% during forecast period.
      In this report, 2018 has been considered as the base year and 2019 to 2025 as the forecast period to estimate the market size for Urolithiasis Management Device.

      This report studies the global market size of Urolithiasis Management Device, especially focuses on the key regions like United States, European Union, China, and other regions (Japan, Korea, India and Southeast Asia).
      This study presents the Urolithiasis Management Device production, revenue, market share and growth rate for each key company, and also covers the breakdown data (production, consumption, revenue and market share) by regions, type and applications. history breakdown data from 2014 to 2019, and forecast to 2025.
      For top companies in United States, European Union and China, this report investigates and analyzes the production, value, price, market share and growth rate for the top manufacturers, key data from 2014 to 2019.

      In global market, the following companies are covered:
      Allengers Medical Systems Ltd.
      Boston Scientific Corporation
      C.R. Bard, Inc.
      Cook Medical
      ConMed Corporation
      DirexGroup
      Dornier MedTech GmbH
      Guangzhou Potent Optotronic Technology Co., Ltd.
      HealthTronics, Inc.
      Karl Storz GmbH & Co. KG
      Lumenis
      Olympus Corporation
      Richard Wolf
      Siemens Healthcare

      Market Segment by Product Type
      Extracorporeal Shock Wave Lithotripsy (Eswl)
      Intracorporeal Lithotripsy
      Percutaneous Nephrolithotomy
      Other Treatments

      Market Segment by Application
      Hospitals
      Clinics
      Other

      Key Regions split in this report: breakdown data for each region.
      United States
      China
      European Union
      Rest of World (Japan, Korea, India and Southeast Asia)

      The study objectives are:
      To analyze and research the Urolithiasis Management Device status and future forecast in United States, European Union and China, involving sales, value (revenue), growth rate (CAGR), market share, historical and forecast.
      To present the key Urolithiasis Management Device manufacturers, presenting the sales, revenue, market share, and recent development for key players.
      To split the breakdown data by regions, type, companies and applications
      To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints and risks.
      To identify significant trends, drivers, influence factors in global and regions
      To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market

      In this study, the years considered to estimate the market size of Urolithiasis Management Device are as follows:
      History Year: 2014-2018
      Base Year: 2018
      Estimated Year: 2019
      Forecast Year 2019 to 2025

      Buy now